Great Place to Work® Designates Selexis as a Best Workplace in Switzerland for Fifth Straight Year
Read MoreWarning About Recruitment Scams
We have been made aware of external parties posing as Selexis recruiters making offers of employment. These scams involve fraudulent communications via instant messaging accounts, phone interviews, fake offer letters, or requests for monetary payment. Any communication you receive from Selexis will come from a @selexis.com email address (not from a free email account such as Yahoo, Gmail, or any other domain outside of “@selexis.com”). We do not ask for monetary payment or sensitive personal information (such as your social security number, personal bank information, or credit card information). If you have any questions about a career opportunity or correspondence related to an open position, please reach out to our team at info@selexis.com.
Meaningful work
An average person spends about 57% of his or her waking time at work during our working life. So, if you have to spend that much time at work, why not have a career with a company that is making a difference? Selexis employees work hard to help partners transform treatments for many serious diseases by developing technology and solutions that no one else in the biopharmaceutical industry can provide.
We value you
At Selexis, we set the bar high for our employees and provide a culture that fosters creativity and innovation. Whether your job involves transfecting cells or marketing our technology and services, we value your contribution to the Company. We have found that employees who feel valued are happier! Happy employees mean happy partners!
Selexis provides a barrier-free workplace and embraces all qualified applicants with varied perspectives and backgrounds. Visit our Diversity Snapshot / Report
Explore the SUREtechnology Platform™
For more than 20 years, Selexis has been at the forefront of helping the biopharmaceutical industry advance life-saving mAb therapeutics into the clinic and to the market.
At Selexis, we believe in the promise of newer biologics and have committed significant resources to ensure our SUREtechnology Platform™ can meet the new expression challenges that these difficult-to-express proteins present.
We are proud of the role that Selexis’ cell line technology is playing in helping to deliver on the promise of bispecifics, which is a rapidly expanding class of drugs showing impressive results in multiple clinical trials.
Selexis SA, a JSR Life Sciences company, is the global leader in cell line development with best-in-class modular technology and highly specialized solutions that enable the life sciences industry to rapidly discover, develop and commercialize innovative medicines and vaccines. Our global partners are utilizing Selexis technologies to advance more than 158 drug products in clinical development and the manufacture of 10 commercial products. As part of a comprehensive drug development process, the Company’s technologies shorten development timelines and reduce manufacturing risks. More information is available at www.selexis.com.
Copyright© 2022 Selexis SA. All Rights Reserved.